Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 2026 entries
View as:

A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)

Phase: N/A Priority: Normal
NCT ID: NCT00697203 Org: User:
Start: 07/31/05 End: 05/31/06 Due: 05/31/07

A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01172847 Org: User:
Start: 08/31/09 End: 02/28/10 Due: 02/28/11

A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01220947 Org: User:
Start: 11/30/10 End: 12/31/12 Due: 12/31/13

A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00531817 Org: User:
Start: 10/31/07 End: 03/31/11 Due: 03/31/12

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01519960 Org: User:
Start: 07/11/12 End: 10/18/21 Due: 10/18/22

A Study of RO5267683 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01398241 Org: User:
Start: 08/31/11 End: 06/30/12 Due: 06/30/13

A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00442793 Org: User:
Start: 05/31/07 End: 05/31/10 Due: 05/31/11

A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Phase: N/A Priority: Normal
NCT ID: NCT02791256 Org: User:
Start: 06/30/05 End: 06/30/08 Due: 06/30/09

A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT03337698 Org: User:
Start: 12/27/17 End: 11/30/26 Due: 11/30/27

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

Phase: N/A Priority: Normal
NCT ID: NCT00129623 Org: User:
Start: 12/31/05 End: 12/31/07 Due: 12/31/08

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01245634 Org: User:
Start: 12/31/10 End: 05/31/13 Due: 05/31/14

BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00528567 Org: User:
Start: 12/31/07 End: 06/30/14 Due: 06/30/15

A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01688206 Org: User:
Start: 10/31/12 End: 03/12/18 Due: 03/12/19

A Study of Prevalence of EGFR Mutations in Participants With NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02695849 Org: User:
Start: 03/31/12 End: 05/31/15 Due: 05/31/16

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04321330 Org: User:
Start: 08/07/20 End: 06/03/24 Due: 06/03/25

A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)

Phase: N/A Priority: Normal
NCT ID: NCT01026142 Org: User:
Start: 01/26/10 End: 08/07/17 Due: 08/07/18

Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT02686619 Org: User:
Start: 11/30/04 End: 01/31/11 Due: 01/31/12

A Study Of Mircera In Patients With Kidney Disease Who Are Not On Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT02490514 Org: User:
Start: 12/31/09 End: 02/29/12 Due: 02/28/13

A Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device.

Phase: N/A Priority: Normal
NCT ID: NCT04751162 Org: User:
Start: 02/18/21 End: 05/01/23 Due: 05/01/24

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

Phase: N/A Priority: Normal
NCT ID: NCT00002377 Org: User:
Start: 01/31/97 End: 12/31/02 Due: 12/31/03

A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01507168 Org: User:
Start: 02/02/12 End: 08/20/15 Due: 08/20/16

Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection

Phase: N/A Priority: Normal
NCT ID: NCT00017784 Org: User:
Start: - End: - Due: -

A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)

Phase: N/A Priority: Normal
NCT ID: NCT01192906 Org: User:
Start: 12/31/10 End: 07/31/14 Due: 07/31/15

A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00321919 Org: User:
Start: 07/31/00 End: 12/31/04 Due: 12/31/05

A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

Phase: N/A Priority: Normal
NCT ID: NCT00760929 Org: User:
Start: 11/10/08 End: 06/25/10 Due: 06/25/11